Louisa L Wirthlin
age ~45
from New York, NY
- Also known as:
-
- Lousie Wirthlin
- Lorrine Wirthlin
- Shawn Tate
Louisa Wirthlin Phones & Addresses
- New York, NY
- Hoboken, NJ
- Saint Louis, MO
- Portland, OR
- Sacramento, CA
Resumes
Medical Science Liaison
view sourceLocation:
676 Riverside Dr, New York, NY 10031
Industry:
Biotechnology
Work:
Washington University In St. Louis Aug 2011 - Apr 2014
Senior Research Technician
Ohsu | Oregon Health & Science University Apr 2010 - Nov 2010
Senior Research Assistant
Uc Davis Jan 2007 - Apr 2010
Staff Scientist Iv
Washington University In St. Louis Aug 2003 - Jan 2007
Research Associate
University of Louisville Jul 2002 - Jul 2003
Research Assistant
Senior Research Technician
Ohsu | Oregon Health & Science University Apr 2010 - Nov 2010
Senior Research Assistant
Uc Davis Jan 2007 - Apr 2010
Staff Scientist Iv
Washington University In St. Louis Aug 2003 - Jan 2007
Research Associate
University of Louisville Jul 2002 - Jul 2003
Research Assistant
Education:
Saint Louis University 1998 - 2002
Skills:
Molecular Biology
Cell Culture
Pcr
Life Sciences
Flow Cytometry
Stem Cell Research
Cell Biology
Qpcr
Biochemistry
Science
Immunohistochemistry
Microscopy
Molecular Cloning
Genetics
Tissue Culture
Fluorescence Microscopy
Elisa
Protein Purification
Confocal Microscopy
Lifesciences
Protein Expression
Cell Culture
Pcr
Life Sciences
Flow Cytometry
Stem Cell Research
Cell Biology
Qpcr
Biochemistry
Science
Immunohistochemistry
Microscopy
Molecular Cloning
Genetics
Tissue Culture
Fluorescence Microscopy
Elisa
Protein Purification
Confocal Microscopy
Lifesciences
Protein Expression
Louisa Wirthlin
view sourceUs Patents
-
Mesenchymal Stem Cells Producing Inhibitory Rna For Disease Modification
view source -
US Patent:20120114618, May 10, 2012
-
Filed:Mar 25, 2010
-
Appl. No.:13/260551
-
Inventors:Jan A. Nolta - Davis CA, US
Scott Olson - Davis CA, US
Louisa Wirthlin - Davis CA, US -
International Classification:A61K 35/12
C12N 5/10
A61P 25/14
C12N 5/0775 -
US Classification:424 937, 435325
-
Abstract:Compositions and methods for delivering a siRNA, dsRNA, or miRNA polynucleotide into a target cell comprising contacting the target cell with a mesenchymal stem cell, which mesenchymal stem cell comprises an exogenous DNA sequence expressing the siRNA or dsRNA polynucleotide, thereby delivering the siRNA, dsRNA, or miRNA polynucleotide to the target cell through a cellular protrusion or a microvesicle.
-
Mesenchymal Stem Cells Producing Inhibitory Rna For Disease Modification
view source -
US Patent:20160263160, Sep 15, 2016
-
Filed:May 23, 2016
-
Appl. No.:15/162418
-
Inventors:- Oakland CA, US
Scott Olson - Davis CA, US
Louisa Wirthlin - Davis CA, US -
International Classification:A61K 35/28
-
Abstract:Compositions and methods for delivering a siRNA, dsRNA, or miRNA polynucleotide into a target cell comprising contacting the target cell with a mesenchymal stem cell, which mesenchymal stem cell comprises an exogenous DNA sequence expressing the siRNA or dsRNA polynucleotide, thereby delivering the siRNA, dsRNA, or miRNA polynucleotide to the target cell through a cellular protrusion or a microvesicle.
Youtube
Get Report for Louisa L Wirthlin from New York, NY, age ~45